PYXS to host webcast with updated Phase 1 MICVO data
Pyxis Oncology will host a webcast to present updated Phase 1 monotherapy data for micvotabart pelidotin (MICVO) in 2L+ recurrent/metastatic head and neck squamous cell carcinoma.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.